Pfizer Will Seek Emergency Approval For Covid-19 Vaccine In November, After Election

The U.S. Food and Drug Administration needs at least two months of safety data before authorizing emergency use of any experimental Covid-19 vaccine.

Source: Forbes.com Healthcare News - October 16, 2020 Category: Pharmaceuticals Authors: Robert Hart, Forbes Staff Tags: Business /business Innovation /innovation Healthcare /healthcare Editors' Pick editors-pick Breaking breaking-news Coronavirus Source Type: news